Decision: Favourable

Study Title:

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with rVWF in Children Diagnosed With Severe von Willebrand disease

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Dr Elizabeth Mary Beatrice Nolan

  • PI Institution:

    CHI Crumlin

  • Sponsor:

    Takeda Development Center Americas, Inc.

Scroll to Top